CYTOVAC A/S: Financial statements 2020
CVR: 31262666
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
CYTOVAC A/S (CVR 31262666) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 1,000,000 and a net result of DKK -15,696,000 compared with DKK -34,142,000 the year before. The profit margin was -1,569.6%. Equity in the 2020 report amounted to DKK -53,631,000.
- Revenue
- DKK 1,000,000
- Profit/Loss
- DKK -15,696,000
- Equity
- DKK -53,631,000
- Total Assets
- DKK 3,513,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 1M | - | -15.7M | -53.6M | - |
| 2019 | - | - | -34.1M | -37.9M | - |
| 2018 | - | - | -30.4M | -3.8M | - |
| 2017 | - | -11.5M | -14.9M | 3.5M | 14 |
| 2016 | - | -9.1M | -12.7M | 9.3M | 12 |
Official annual report
How creditworthy is CYTOVAC A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
CYTOVAC A/S has published its annual report for 2019. The net result was DKK -34,142,000.
As of March 3, 2020, Lars Peter Bjerrek has left the board of directors of CYTOVAC A/S.
As of January 1, 2020, Lone Dahl Andersen is registered as adm. dir. of CYTOVAC A/S.
As of January 1, 2020, Kim Arvid Nielsen has stepped down as adm. dir. of CYTOVAC A/S.
About CYTOVAC A/S
CYTOVAC A/S was a Danish company of the type Aktieselskab based in København K, founded in 2008. The company has been dissolved on 16 January 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a net result of DKK -15,319,000 compared with DKK -6,277,000 the year before. Equity in the 2023 report amounted to DKK -88,579,000.